Maxcyte (MXCT) Retained Earnings (2020 - 2026)

Maxcyte (MXCT) has 7 years of Retained Earnings data on file, last reported at -$266.2 million in Q1 2026.

• On a quarterly basis, Retained Earnings fell 17.22% year-over-year to -$266.2 million in Q1 2026; TTM through Mar 2026 was -$266.2 million, a 17.22% decrease from a year earlier, with the FY2025 full-year figure at $431.9 million, up 299.17% from the prior year.
• Retained Earnings for Q1 2026 stood at -$266.2 million, down from $431.9 million in the prior quarter.
• Over the last five years, Retained Earnings for MXCT reached as high as $431.9 million in Q4 2025 and fell as low as -$266.2 million in Q1 2026.
• Historically, Retained Earnings has averaged $16.9 million across 5 years, with a median of -$159.3 million in 2023.
• Across the five-year window, Retained Earnings surged 453.17% in 2022 and sank 153.29% in 2024, its largest moves.
• Year by year, Retained Earnings stood at -$137.9 million in 2022, then surged by 395.14% to $406.9 million in 2023, then sank by 153.29% to -$216.9 million in 2024, then surged by 299.17% to $431.9 million in 2025, then plunged by 161.64% to -$266.2 million in 2026.
• Per Business Quant data, the three most recent Retained Earnings figures were -$266.2 million in Q1 2026, $431.9 million in Q4 2025, and -$251.9 million in Q3 2025.